IFN-γ also stimulates an anti-tumor environment by increasing expression of classical MHC class I genes, cytotoxicity, effector functions, CD4+ and CD8+ T cell proliferation, and survival, while also decreasing Treg suppressive activity and endothelial cell proliferation [4,36,37]. The gene discussed is IFNG; the disease is neoplasm.